Hydreight Technologies Inc. (TSXV:NURS)

Market Cap	204.47M +61.7%
Revenue (ttm)	55.78M +224.1%
Net Income	4.26M
EPS	0.09
Shares Out	53.67M
PE Ratio	42.90
Forward PE	10.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,363
Open	4.120
Previous Close	3.950
Day's Range	3.790 - 4.130
52-Week Range	2.380 - 5.590
Beta	0.65
Analysts	Buy
Price Target	9.25 (+142.15%)
Earnings Date	Aug 27, 2026

About Hydreight Technologies

Hydreight Technologies Inc. operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmaci...

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Shane Madden
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NURS

Analyst Summary

According to 3 analysts, the average rating for NURS stock is "Buy." The 12-month stock price target is $9.25, which is an increase of 142.15% from the latest price.

Price Target

$9.25

(142.15% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 10, 2026

Data Sources Report a data error